NCT07223684 is a clinical trial of Observational Cohort (No Intervention) in Sepsis, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

Who is sponsoring NCT07223684?

NCT07223684 is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

What drugs are being tested in NCT07223684?

Interventions in NCT07223684: Observational Cohort (No Intervention).

What condition does NCT07223684 study?

NCT07223684 studies Sepsis, Burn Injury, Wound Healing, Critical Illness, Multiple Organ Dysfunction Syndrome.

Is NCT07223684 still recruiting?

NCT07223684 is currently not yet recruiting. Last updated 4 February 2026.

Last reviewed 2026-02-04 · How we verify

NCT07223684

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TDAP in Burn Patients (Group 2)

Not yet recruiting Last updated 4 February 2026

What this trial tests

trial testing Observational Cohort (No Intervention) in Sepsis in 80 participants. Not yet recruiting.

Timeline

15 May 2026

Primary endpoint
15 June 2027

15 December 2027

Quick facts

Lead sponsor	Henry M. Jackson Foundation for the Advancement of Military Medicine
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	80
Start date	15 May 2026
Primary completion	15 June 2027
Estimated completion	15 December 2027
Sites	3 locations across United States

Drugs / interventions tested

Observational Cohort (No Intervention)

Conditions studied

Sepsis — all drugs for Sepsis →
Burn Injury — all drugs for Burn Injury →
Wound Healing — all drugs for Wound Healing →
Critical Illness — all drugs for Critical Illness →

Sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicine

Who can join

Adults 18 to 80, any sex, with Sepsis or Burn Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is following adult patients with serious burn injuries to better understand how their bodies respond to treatment and recovery. Researchers will collect small amounts of blood and tissue samples, along with information already recorded in the medical record, such as vital signs, lab results, and details of surgeries or complications. The goal is to identify patterns that may help predict who is at higher risk for infections or other problems after a burn injury. This information could lead to new tools, including computer-based models, to improve burn care and outcomes in the future. Participation involves providing samples and allowing researchers to review medical records during the hospital stay and up to one year after discharge.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Observational Cohort (No Intervention)

Trials testing the same drug.

NCT07249762 — Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robu · not yet recruiting

Other recruiting trials for Sepsis

Currently open trials in the same condition.

NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting

Other Henry M. Jackson Foundation for the Advancement of Military Medicine trials

Trials by the same sponsor.

NCT07249762 — Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robu · not yet recruiting
NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
NCT06885554 — Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation · NA · recruiting
NCT06855186 — Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C) · NA · recruiting
NCT06484335 — RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07223684 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Henry M. Jackson Foundation for the Advancement of Military Medicine
Last refreshed: 4 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07223684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing